This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Diehl, L. J. Articles by Hoover, E. A. Search for Related Content PubMed PubMed Citation Articles by Diehl, L. J. Articles by Hoover, E. A.

 Previous Article  |  Next Article 

J. Virol., 04 1995, 2328-2332, Vol 69, No. 4
Copyright © 1995, American Society for Microbiology

Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR

LJ Diehl, CK Mathiason-DuBard, LL O'Neil and EA Hoover
Department of Pathology, Colorado State University, Fort Collins 80523.

Cats infected with feline immunodeficiency virus (FIV) develop a disease syndrome similar to that caused by human immunodeficiency virus type 1 (HIV-1) infection in humans. HIV-1 replication has been shown to correlate with the disease stage and progression. To assess replication kinetics and disease progression in early FIV infection, we developed a quantitative competitive reverse transcriptase PCR to measure the plasma virus load at serial time points after virus exposure. We found that an early peak viremia immediately preceded the onset of acute- phase symptoms in infected cats. Plasma virus levels remained high throughout the symptomatic phase of infection, which lasted for 8 to 10 weeks, and then declined as clinical symptoms resolved; however, all cats maintained significant plasma virus titers through 36 weeks postinfection. Early peak viral replication coincided with the initial precipitous decline in circulating CD4+ T lymphocytes. These results indicate that FIV kinetics are similar to those of HIV-1 during the acute and secondary phase of infection and that the plasma FIV load correlates with the disease stage. These results serve to further develop the FIV model and to enhance its usefulness for pathogenesis, vaccine development, and therapeutic studies related to HIV.

This article has been cited by other articles:

• Willett, B. J., McMonagle, E. L., Ridha, S., Hosie, M. J. (2006). Differential Utilization of CD134 as a Functional Receptor by Diverse Strains of Feline Immunodeficiency Virus.. J. Virol. 80: 3386-3394 [Abstract] [Full Text]  
• Stewart, M., Desport, M., Hartaningsih, N., Wilcox, G. (2005). TaqMan Real-Time Reverse Transcription-PCR and JDVp26 Antigen Capture Enzyme-Linked Immunosorbent Assay To Quantify Jembrana Disease Virus Load during the Acute Phase of In Vivo Infection. J. Clin. Microbiol. 43: 5574-5580 [Abstract] [Full Text]  
• de Rozieres, S., Mathiason, C. K., Rolston, M. R., Chatterji, U., Hoover, E. A., Elder, J. H. (2004). Characterization of a Highly Pathogenic Molecular Clone of Feline Immunodeficiency Virus Clade C. J. Virol. 78: 8971-8982 [Abstract] [Full Text]  
• Avery, P. R., Hoover, E. A. (2004). Gamma Interferon/Interleukin 10 Balance in Tissue Lymphocytes Correlates with Down Modulation of Mucosal Feline Immunodeficiency Virus Infection. J. Virol. 78: 4011-4019 [Abstract] [Full Text]  
• D'Cruz, O. J., Waurzyniak, B., Uckun, F. M. (2004). Antiretroviral Spermicide WHI-07 Prevents Vaginal and Rectal Transmission of Feline Immunodeficiency Virus in Domestic Cats. Antimicrob. Agents Chemother. 48: 1082-1088 [Abstract] [Full Text]  
• Ryan, G., Klein, D., Knapp, E., Hosie, M. J., Grimes, T., Mabruk, M. J. E. M. F., Jarrett, O., Callanan, J. J. (2003). Dynamics of Viral and Proviral Loads of Feline Immunodeficiency Virus within the Feline Central Nervous System during the Acute Phase following Intravenous Infection. J. Virol. 77: 7477-7485 [Abstract] [Full Text]  
• Rogers, A. B., Mathiason, C. K., Hoover, E. A. (2002). Immunohistochemical Localization of Feline Immunodeficiency Virus Using Native Species Antibodies. Am. J. Pathol. 161: 1143-1151 [Abstract] [Full Text]  
• Goto, Y., Nishimura, Y., Baba, K., Mizuno, T., Endo, Y., Masuda, K., Ohno, K., Tsujimoto, H. (2002). Association of Plasma Viral RNA Load with Prognosis in Cats Naturally Infected with Feline Immunodeficiency Virus. J. Virol. 76: 10079-10083 [Abstract] [Full Text]  
• Hayes, K. A., Phipps, A. J., Francke, S., Mathes, L. E. (2000). Antiviral Therapy Reduces Viral Burden but Does Not Prevent Thymic Involution in Young Cats Infected with Feline Immunodeficiency Virus. Antimicrob. Agents Chemother. 44: 2399-2405 [Abstract] [Full Text]  
• Obert, L. A., Hoover, E. A. (2000). Relationship of Lymphoid Lesions to Disease Course in Mucosal Feline Immunodeficiency Virus Type C Infection. Vet Pathol 37: 386-401 [Abstract] [Full Text]  
• Johnston, J., Power, C. (1999). Productive Infection of Human Peripheral Blood Mononuclear Cells by Feline Immunodeficiency Virus: Implications for Vector Development. J. Virol. 73: 2491-2498 [Abstract] [Full Text]  
• Richardson, J., Moraillon, A., Crespeau, F., Baud, S., Sonigo, P., Pancino, G. (1998). Delayed Infection after Immunization with a Peptide from the Transmembrane Glycoprotein of the Feline Immunodeficiency Virus. J. Virol. 72: 2406-2415 [Abstract] [Full Text]